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Background
Fibrosis is thought to play an important role in the
pathogenesis of the adverse sequelae of hypertrophic
cardiomyopathy (HCM). Late gadolinium enhancement
(LGE) cardiovascular magnetic resonance detects repla-
cement fibrosis but cannot presently detect interstitial
fibrosis. The latter is thought to be a very early feature
of HCM and can be triggered by inflammation, which
can also expand the size of the myocardial interstitium.
We sought to determine whether extracellular volume
(ECV) mapping by T1-relaxometry in concert with T2-
mapping can identify interstitial changes in HCM and
whether these were related to myocardial edema.
Methods
Twenty HCM patients (mean±SD age: 59.9±9.1 years, 15
male) and 13 healthy volunteers (46.1±11.5 years, 7 male)
were studied. Left ventricular T1 and T2 maps were
acquired at the base, mid-ventricle and apex in patients
and at the mid-ventricle in controls using a modified
Look-Locker inversion recovery sequence and a T2-pre-
pared steady-state free precession mapping sequence.
Post-contrast T1 maps were acquired a minimum of 15
min after 0.1 mmol/kg gadolinium together with conven-
tional LGE images. After motion correction, pre- and
post-contrast T1 parameter maps were co-registered to
generate ECV parameter maps. Parameter maps and LGE
images were viewed side-by-side and regions of interest
(ROI) were drawn in areas with and without LGE. Data
were analysed using a linear mixed effects model to
account for clustering of ROI within patients.
Results
ROI analysis revealed a significantly higher ECV in
regions with LGE relative to controls (0.389±0.087 ver-
sus 0.278±0.019, P<0.001)[Figure 1]. However, when
compared with controls, there was no significant differ-
ence in the ECV of regions from HCM patients that
were free of LGE (0.300±0.029 versus 0.278±0.019,
P=0.199). T2-times in regions with LGE were similar to
controls (55.4±2.6 ms versus 54.9±1.8 ms, P=0.337,
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Figure 1 Extracellular Volume Fraction (ECV) in areas with and
without Late Gadolinium Enhancement (LGE) in patients with
Hypertrophic Cardiomyopathy versus healthy controls.
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respectively) as were the T2 times obtained for regions
free of LGE (55.7±2.7 ms versus 54.9±1.8 ms, P=0.309).
Conclusions
ECV mapping in HCM detects replacement fibrosis, but
was unable to detect interstitial fibrosis. There was no
evidence of edema in areas of LGE suggesting that this
was not a major contributor to ECV expansion in our
HCM cohort.
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Table 1
Characteristic - Mean±SD Controls (n=13) Hypertrophic Cardiomyopathy (n=20) P value
Male - n(%) 7 (53.9) 15 (75.0) 0.208
Age - years 46.1±11.5 59.9±9.1 <0.001
Hematocrit 0.41±0.04 0.41±0.03 0.869
LV wall thickness - mm 8.4±1.5 20.7±3.8 <0.001
LV-EDV index - ml/m2 78.9±12.0 69.7±12.9 0.047
LV-ESV index - ml/m2 25.0±7.1 19.3±6.8 0.027
LV ejection fraction - % 68.8±6.1 72.8±6.9 0.101
LV Mass Index - g/m2 57.4±11.6 93.8±26.0 <0.001
LV=Left Ventricular; LV-EDV=Left Ventricular End-diastolic volume; LV-ESV=Left Ventricular End-systolic volume.
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